img

Global Metastatic Melanoma Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Metastatic Melanoma Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Metastatic Melanoma Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Metastatic Melanoma Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Metastatic Melanoma Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Metastatic Melanoma Drug key manufacturers include Merck & Co., Inc., Merck KGaA, Millennium Pharmaceuticals, Inc., Morphotek, Inc., NewLink Genetics Corporation, Novartis AG, Omeros Corporation, Oncolytics Biotech Inc. and OncoSec Medical Inc., etc. Merck & Co., Inc., Merck KGaA, Millennium Pharmaceuticals, Inc. are top 3 players and held % sales share in total in 2022.
Metastatic Melanoma Drug can be divided into AGI-134, ALT-801, ALT-803 and AMG-232, etc. AGI-134 is the mainstream product in the market, accounting for % sales share globally in 2022.
Metastatic Melanoma Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Metastatic Melanoma Drug industry development. In 2022, global % sales of Metastatic Melanoma Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Metastatic Melanoma Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co., Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.
Morphotek, Inc.
NewLink Genetics Corporation
Novartis AG
Omeros Corporation
Oncolytics Biotech Inc.
OncoSec Medical Inc.
Ono Pharmaceutical Co., Ltd.
Pfizer Inc.
Pharmis Biofarmaceutica, Lda.
Philogen S.p.A.
Plexxikon Inc.
Segment by Type
AGI-134
ALT-801
ALT-803
AMG-232
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Metastatic Melanoma Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Metastatic Melanoma Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Metastatic Melanoma Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Metastatic Melanoma Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Metastatic Melanoma Drug introduction, etc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Metastatic Melanoma Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Metastatic Melanoma Drug Market Overview
1.1 Metastatic Melanoma Drug Product Overview
1.2 Metastatic Melanoma Drug Market Segment by Type
1.2.1 AGI-134
1.2.2 ALT-801
1.2.3 ALT-803
1.2.4 AMG-232
1.2.5 Others
1.3 Global Metastatic Melanoma Drug Market Size by Type
1.3.1 Global Metastatic Melanoma Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Metastatic Melanoma Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Metastatic Melanoma Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Metastatic Melanoma Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Metastatic Melanoma Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Metastatic Melanoma Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Metastatic Melanoma Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Metastatic Melanoma Drug Sales Breakdown by Type (2018-2024)
2 Global Metastatic Melanoma Drug Market Competition by Company
2.1 Global Top Players by Metastatic Melanoma Drug Sales (2018-2024)
2.2 Global Top Players by Metastatic Melanoma Drug Revenue (2018-2024)
2.3 Global Top Players by Metastatic Melanoma Drug Price (2018-2024)
2.4 Global Top Manufacturers Metastatic Melanoma Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Metastatic Melanoma Drug Market Competitive Situation and Trends
2.5.1 Metastatic Melanoma Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Metastatic Melanoma Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Melanoma Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Metastatic Melanoma Drug Market
2.8 Key Manufacturers Metastatic Melanoma Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Metastatic Melanoma Drug Status and Outlook by Region
3.1 Global Metastatic Melanoma Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Metastatic Melanoma Drug Historic Market Size by Region
3.2.1 Global Metastatic Melanoma Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Metastatic Melanoma Drug Sales in Value by Region (2018-2024)
3.2.3 Global Metastatic Melanoma Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Metastatic Melanoma Drug Forecasted Market Size by Region
3.3.1 Global Metastatic Melanoma Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Metastatic Melanoma Drug Sales in Value by Region (2024-2034)
3.3.3 Global Metastatic Melanoma Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Metastatic Melanoma Drug by Application
4.1 Metastatic Melanoma Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Metastatic Melanoma Drug Market Size by Application
4.2.1 Global Metastatic Melanoma Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Metastatic Melanoma Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Metastatic Melanoma Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Metastatic Melanoma Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Metastatic Melanoma Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Metastatic Melanoma Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Metastatic Melanoma Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Metastatic Melanoma Drug Sales Breakdown by Application (2018-2024)
5 North America Metastatic Melanoma Drug by Country
5.1 North America Metastatic Melanoma Drug Historic Market Size by Country
5.1.1 North America Metastatic Melanoma Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Metastatic Melanoma Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Metastatic Melanoma Drug Sales in Value by Country (2018-2024)
5.2 North America Metastatic Melanoma Drug Forecasted Market Size by Country
5.2.1 North America Metastatic Melanoma Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Metastatic Melanoma Drug Sales in Value by Country (2024-2034)
6 Europe Metastatic Melanoma Drug by Country
6.1 Europe Metastatic Melanoma Drug Historic Market Size by Country
6.1.1 Europe Metastatic Melanoma Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Metastatic Melanoma Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Metastatic Melanoma Drug Sales in Value by Country (2018-2024)
6.2 Europe Metastatic Melanoma Drug Forecasted Market Size by Country
6.2.1 Europe Metastatic Melanoma Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Metastatic Melanoma Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Metastatic Melanoma Drug by Region
7.1 Asia-Pacific Metastatic Melanoma Drug Historic Market Size by Region
7.1.1 Asia-Pacific Metastatic Melanoma Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Metastatic Melanoma Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Metastatic Melanoma Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Metastatic Melanoma Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Metastatic Melanoma Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Metastatic Melanoma Drug Sales in Value by Region (2024-2034)
8 Latin America Metastatic Melanoma Drug by Country
8.1 Latin America Metastatic Melanoma Drug Historic Market Size by Country
8.1.1 Latin America Metastatic Melanoma Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Metastatic Melanoma Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Metastatic Melanoma Drug Sales in Value by Country (2018-2024)
8.2 Latin America Metastatic Melanoma Drug Forecasted Market Size by Country
8.2.1 Latin America Metastatic Melanoma Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Metastatic Melanoma Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Metastatic Melanoma Drug by Country
9.1 Middle East and Africa Metastatic Melanoma Drug Historic Market Size by Country
9.1.1 Middle East and Africa Metastatic Melanoma Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Metastatic Melanoma Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Metastatic Melanoma Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Metastatic Melanoma Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Metastatic Melanoma Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Metastatic Melanoma Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck & Co., Inc.
10.1.1 Merck & Co., Inc. Company Information
10.1.2 Merck & Co., Inc. Introduction and Business Overview
10.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck & Co., Inc. Metastatic Melanoma Drug Products Offered
10.1.5 Merck & Co., Inc. Recent Development
10.2 Merck KGaA
10.2.1 Merck KGaA Company Information
10.2.2 Merck KGaA Introduction and Business Overview
10.2.3 Merck KGaA Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck KGaA Metastatic Melanoma Drug Products Offered
10.2.5 Merck KGaA Recent Development
10.3 Millennium Pharmaceuticals, Inc.
10.3.1 Millennium Pharmaceuticals, Inc. Company Information
10.3.2 Millennium Pharmaceuticals, Inc. Introduction and Business Overview
10.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Products Offered
10.3.5 Millennium Pharmaceuticals, Inc. Recent Development
10.4 Morphotek, Inc.
10.4.1 Morphotek, Inc. Company Information
10.4.2 Morphotek, Inc. Introduction and Business Overview
10.4.3 Morphotek, Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Morphotek, Inc. Metastatic Melanoma Drug Products Offered
10.4.5 Morphotek, Inc. Recent Development
10.5 NewLink Genetics Corporation
10.5.1 NewLink Genetics Corporation Company Information
10.5.2 NewLink Genetics Corporation Introduction and Business Overview
10.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 NewLink Genetics Corporation Metastatic Melanoma Drug Products Offered
10.5.5 NewLink Genetics Corporation Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis AG Metastatic Melanoma Drug Products Offered
10.6.5 Novartis AG Recent Development
10.7 Omeros Corporation
10.7.1 Omeros Corporation Company Information
10.7.2 Omeros Corporation Introduction and Business Overview
10.7.3 Omeros Corporation Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Omeros Corporation Metastatic Melanoma Drug Products Offered
10.7.5 Omeros Corporation Recent Development
10.8 Oncolytics Biotech Inc.
10.8.1 Oncolytics Biotech Inc. Company Information
10.8.2 Oncolytics Biotech Inc. Introduction and Business Overview
10.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Oncolytics Biotech Inc. Metastatic Melanoma Drug Products Offered
10.8.5 Oncolytics Biotech Inc. Recent Development
10.9 OncoSec Medical Inc.
10.9.1 OncoSec Medical Inc. Company Information
10.9.2 OncoSec Medical Inc. Introduction and Business Overview
10.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 OncoSec Medical Inc. Metastatic Melanoma Drug Products Offered
10.9.5 OncoSec Medical Inc. Recent Development
10.10 Ono Pharmaceutical Co., Ltd.
10.10.1 Ono Pharmaceutical Co., Ltd. Company Information
10.10.2 Ono Pharmaceutical Co., Ltd. Introduction and Business Overview
10.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Products Offered
10.10.5 Ono Pharmaceutical Co., Ltd. Recent Development
10.11 Pfizer Inc.
10.11.1 Pfizer Inc. Company Information
10.11.2 Pfizer Inc. Introduction and Business Overview
10.11.3 Pfizer Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Pfizer Inc. Metastatic Melanoma Drug Products Offered
10.11.5 Pfizer Inc. Recent Development
10.12 Pharmis Biofarmaceutica, Lda.
10.12.1 Pharmis Biofarmaceutica, Lda. Company Information
10.12.2 Pharmis Biofarmaceutica, Lda. Introduction and Business Overview
10.12.3 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Products Offered
10.12.5 Pharmis Biofarmaceutica, Lda. Recent Development
10.13 Philogen S.p.A.
10.13.1 Philogen S.p.A. Company Information
10.13.2 Philogen S.p.A. Introduction and Business Overview
10.13.3 Philogen S.p.A. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Philogen S.p.A. Metastatic Melanoma Drug Products Offered
10.13.5 Philogen S.p.A. Recent Development
10.14 Plexxikon Inc.
10.14.1 Plexxikon Inc. Company Information
10.14.2 Plexxikon Inc. Introduction and Business Overview
10.14.3 Plexxikon Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Plexxikon Inc. Metastatic Melanoma Drug Products Offered
10.14.5 Plexxikon Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Metastatic Melanoma Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Metastatic Melanoma Drug Industrial Chain Analysis
11.4 Metastatic Melanoma Drug Market Dynamics
11.4.1 Metastatic Melanoma Drug Industry Trends
11.4.2 Metastatic Melanoma Drug Market Drivers
11.4.3 Metastatic Melanoma Drug Market Challenges
11.4.4 Metastatic Melanoma Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Metastatic Melanoma Drug Distributors
12.3 Metastatic Melanoma Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AGI-134
Table 2. Major Company of ALT-801
Table 3. Major Company of ALT-803
Table 4. Major Company of AMG-232
Table 5. Major Company of Others
Table 6. Global Metastatic Melanoma Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Metastatic Melanoma Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Metastatic Melanoma Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Metastatic Melanoma Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Metastatic Melanoma Drug Market Share in Value by Type (2018-2024)
Table 11. Global Metastatic Melanoma Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Metastatic Melanoma Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Metastatic Melanoma Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Metastatic Melanoma Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Metastatic Melanoma Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Metastatic Melanoma Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Metastatic Melanoma Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Metastatic Melanoma Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Metastatic Melanoma Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Metastatic Melanoma Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Metastatic Melanoma Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Metastatic Melanoma Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Metastatic Melanoma Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Metastatic Melanoma Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Metastatic Melanoma Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Metastatic Melanoma Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Metastatic Melanoma Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Metastatic Melanoma Drug Sales Share by Company (2018-2024)
Table 29. Global Metastatic Melanoma Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Metastatic Melanoma Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Metastatic Melanoma Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Metastatic Melanoma Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Metastatic Melanoma Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Melanoma Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Metastatic Melanoma Drug Market
Table 36. Key Manufacturers Metastatic Melanoma Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Metastatic Melanoma Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Metastatic Melanoma Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Metastatic Melanoma Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Metastatic Melanoma Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Metastatic Melanoma Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Metastatic Melanoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Metastatic Melanoma Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Metastatic Melanoma Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Metastatic Melanoma Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Metastatic Melanoma Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Metastatic Melanoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Metastatic Melanoma Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Metastatic Melanoma Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Metastatic Melanoma Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Metastatic Melanoma Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Metastatic Melanoma Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Metastatic Melanoma Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Metastatic Melanoma Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Metastatic Melanoma Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Metastatic Melanoma Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Metastatic Melanoma Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Metastatic Melanoma Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Metastatic Melanoma Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Metastatic Melanoma Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Metastatic Melanoma Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Metastatic Melanoma Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Metastatic Melanoma Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Metastatic Melanoma Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Metastatic Melanoma Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Metastatic Melanoma Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Metastatic Melanoma Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Metastatic Melanoma Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Metastatic Melanoma Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Metastatic Melanoma Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Metastatic Melanoma Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Metastatic Melanoma Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Metastatic Melanoma Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Metastatic Melanoma Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Metastatic Melanoma Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Metastatic Melanoma Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Metastatic Melanoma Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Metastatic Melanoma Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Metastatic Melanoma Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Metastatic Melanoma Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Metastatic Melanoma Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Metastatic Melanoma Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Metastatic Melanoma Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Metastatic Melanoma Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Metastatic Melanoma Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Metastatic Melanoma Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Metastatic Melanoma Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Metastatic Melanoma Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Metastatic Melanoma Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Metastatic Melanoma Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Metastatic Melanoma Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Metastatic Melanoma Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Metastatic Melanoma Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Metastatic Melanoma Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Metastatic Melanoma Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Merck & Co., Inc. Company Information
Table 111. Merck & Co., Inc. Introduction and Business Overview
Table 112. Merck & Co., Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Merck & Co., Inc. Metastatic Melanoma Drug Product
Table 114. Merck & Co., Inc. Recent Development
Table 115. Merck KGaA Company Information
Table 116. Merck KGaA Introduction and Business Overview
Table 117. Merck KGaA Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Merck KGaA Metastatic Melanoma Drug Product
Table 119. Merck KGaA Recent Development
Table 120. Millennium Pharmaceuticals, Inc. Company Information
Table 121. Millennium Pharmaceuticals, Inc. Introduction and Business Overview
Table 122. Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Product
Table 124. Millennium Pharmaceuticals, Inc. Recent Development
Table 125. Morphotek, Inc. Company Information
Table 126. Morphotek, Inc. Introduction and Business Overview
Table 127. Morphotek, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Morphotek, Inc. Metastatic Melanoma Drug Product
Table 129. Morphotek, Inc. Recent Development
Table 130. NewLink Genetics Corporation Company Information
Table 131. NewLink Genetics Corporation Introduction and Business Overview
Table 132. NewLink Genetics Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. NewLink Genetics Corporation Metastatic Melanoma Drug Product
Table 134. NewLink Genetics Corporation Recent Development
Table 135. Novartis AG Company Information
Table 136. Novartis AG Introduction and Business Overview
Table 137. Novartis AG Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Novartis AG Metastatic Melanoma Drug Product
Table 139. Novartis AG Recent Development
Table 140. Omeros Corporation Company Information
Table 141. Omeros Corporation Introduction and Business Overview
Table 142. Omeros Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Omeros Corporation Metastatic Melanoma Drug Product
Table 144. Omeros Corporation Recent Development
Table 145. Oncolytics Biotech Inc. Company Information
Table 146. Oncolytics Biotech Inc. Introduction and Business Overview
Table 147. Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Oncolytics Biotech Inc. Metastatic Melanoma Drug Product
Table 149. Oncolytics Biotech Inc. Recent Development
Table 150. OncoSec Medical Inc. Company Information
Table 151. OncoSec Medical Inc. Introduction and Business Overview
Table 152. OncoSec Medical Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. OncoSec Medical Inc. Metastatic Melanoma Drug Product
Table 154. OncoSec Medical Inc. Recent Development
Table 155. Ono Pharmaceutical Co., Ltd. Company Information
Table 156. Ono Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 157. Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Product
Table 159. Ono Pharmaceutical Co., Ltd. Recent Development
Table 160. Pfizer Inc. Company Information
Table 161. Pfizer Inc. Introduction and Business Overview
Table 162. Pfizer Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Pfizer Inc. Metastatic Melanoma Drug Product
Table 164. Pfizer Inc. Recent Development
Table 165. Pharmis Biofarmaceutica, Lda. Company Information
Table 166. Pharmis Biofarmaceutica, Lda. Introduction and Business Overview
Table 167. Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Product
Table 169. Pharmis Biofarmaceutica, Lda. Recent Development
Table 170. Philogen S.p.A. Company Information
Table 171. Philogen S.p.A. Introduction and Business Overview
Table 172. Philogen S.p.A. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Philogen S.p.A. Metastatic Melanoma Drug Product
Table 174. Philogen S.p.A. Recent Development
Table 175. Plexxikon Inc. Company Information
Table 176. Plexxikon Inc. Introduction and Business Overview
Table 177. Plexxikon Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. Plexxikon Inc. Metastatic Melanoma Drug Product
Table 179. Plexxikon Inc. Recent Development
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Metastatic Melanoma Drug Market Trends
Table 183. Metastatic Melanoma Drug Market Drivers
Table 184. Metastatic Melanoma Drug Market Challenges
Table 185. Metastatic Melanoma Drug Market Restraints
Table 186. Metastatic Melanoma Drug Distributors List
Table 187. Metastatic Melanoma Drug Downstream Customers
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Metastatic Melanoma Drug Product Picture
Figure 2. Global Metastatic Melanoma Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Metastatic Melanoma Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Metastatic Melanoma Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AGI-134
Figure 6. Global AGI-134 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of ALT-801
Figure 8. Global ALT-801 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of ALT-803
Figure 10. Global ALT-803 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of AMG-232
Figure 12. Global AMG-232 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Metastatic Melanoma Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Metastatic Melanoma Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Metastatic Melanoma Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Metastatic Melanoma Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Metastatic Melanoma Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Metastatic Melanoma Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Metastatic Melanoma Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Metastatic Melanoma Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Metastatic Melanoma Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Metastatic Melanoma Drug Revenue in 2022
Figure 29. Metastatic Melanoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Metastatic Melanoma Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Metastatic Melanoma Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Metastatic Melanoma Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Metastatic Melanoma Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Metastatic Melanoma Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Metastatic Melanoma Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Metastatic Melanoma Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Metastatic Melanoma Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Metastatic Melanoma Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Metastatic Melanoma Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Metastatic Melanoma Drug Manufacturing Cost Structure
Figure 49. Metastatic Melanoma Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries